You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CARBOPROST TROMETHAMINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for carboprost tromethamine and what is the scope of freedom to operate?

Carboprost tromethamine is the generic ingredient in two branded drugs marketed by Alembic, Amneal, Ani Pharms, Caplin, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Long Grove Pharms, Micro Labs, Sola Pharms, Steriscience Speclts, Sunny, and Pfizer, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for carboprost tromethamine. Eighteen suppliers are listed for this compound.

Summary for CARBOPROST TROMETHAMINE
US Patents:0
Tradenames:2
Applicants:13
NDAs:13
Drug Master File Entries: 1
Finished Product Suppliers / Packagers: 18
Raw Ingredient (Bulk) Api Vendors: 40
Clinical Trials: 3
Patent Applications: 369
What excipients (inactive ingredients) are in CARBOPROST TROMETHAMINE?CARBOPROST TROMETHAMINE excipients list
DailyMed Link:CARBOPROST TROMETHAMINE at DailyMed
Recent Clinical Trials for CARBOPROST TROMETHAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwestern UniversityEarly Phase 1
C.R.Darnall Army Medical CenterN/A
American University of Beirut Medical CenterN/A

See all CARBOPROST TROMETHAMINE clinical trials

Pharmacology for CARBOPROST TROMETHAMINE
Medical Subject Heading (MeSH) Categories for CARBOPROST TROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPROST TROMETHAMINE

US Patents and Regulatory Information for CARBOPROST TROMETHAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Steriscience Speclts CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 216897-001 Jul 25, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Caplin CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 216882-001 Feb 13, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer HEMABATE carboprost tromethamine INJECTABLE;INJECTION 017989-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 218013-001 Apr 3, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 216939-001 May 25, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 215337-001 Jan 27, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.